Human Angiotensin II Type 1 Receptor Isoforms Encoded by Messenger RNA Splice Variants Are Functionally Distinct
Human Angiotensin II Type 1
Receptor Isoforms Encoded by
Messenger RNA Splice Variants Are
Functionally Distinct
Mickey M. Martin, Barry M. Willardson, Gregory F. Burton,
C. Roger White, Joseph N. McLaughlin, Steven M. Bray,
James W. Ogilvie, Jr., and Terry S. Elton
Department of Chemistry and Biochemistry (M.M.M., B.M.W.,
J.N.M., S.M.B., J.W.O., T.S.E.)
Department of Microbiology (G.F.B.)
Brigham Young University
Provo, Utah 84602
University of Alabama at Birmingham
Vascular Biology and Hypertension Program (C.R.W.)
Birmingham, Alabama 35294
lar smooth muscle cells (2–4), renal mesangial cells (5),
cardiomyocytes (6), and cardiac fibroblasts (7). This
mitogenic response requires the rapid activation of
one or several mitogen-activated protein kinases including extracellular signal-regulated kinases 1/2 (ERK
1/2), stress-activated C-Jun N-terminal kinases, and
p38 mitogen-activated protein kinase (8).
The biological responses to Ang II are mediated by its
interaction with high affinity G protein-coupled receptors
(GPCRs) localized on the surface of target cells (9). Two
main Ang II receptor subtypes, AT1R and AT2R, have
been pharmacologically identified (10). AT1R activation
by Ang II stimulates phosphatidylinositol-specific phospholipase C, leading to the generation of inositol
trisphosphate and diacylglycerol, which are involved in
intracellular Ca2⫹ mobilization (11, 12) and protein kinase
C activation (13). AT1R activation by Ang II also stimulates the ERK 1/2 cascade (14); however, the coupling
mechanisms between the AT1R and the ERK 1/2 cascade are still incompletely characterized. Recent investigations suggest that Ang II activates ERK 1/2 through
transactivation of tyrosine kinase receptors, which appears to be mediated by several nonreceptor tyrosine
kinases, including the proline-rich tyrosine kinase 2
(PYK2) and Src family tyrosine kinases (14–21). Transactivation results in Shc-Grb2-SOS complex formation and
RAS activation, which in turn initiates a kinase cascade
culminating in ERK 1/2 activation (22, 23). In contrast, the
signaling pathways of the AT2R are not well defined.
Although the exact physiological function of the AT2R is
not clear, studies utilizing vascular smooth muscle cells
(24) or coronary endothelial cells (25) suggest that the
AT2R inhibits proliferation. Thus, the AT2R may antagonize the growth-promoting effects of the AT1R.
Recently, our laboratory (26, 27) and others (28, 29)
have demonstrated that the human AT1R (hAT1R) gene is
Human tissues that express the angiotensin II (Ang
II) type 1 receptor (hAT1R) can synthesize four distinct alternatively spliced hAT1R mRNA transcripts.
In this study, we show that the relative abundance
of these mRNA transcripts varies widely in human
tissues, suggesting that each splice variant is functionally distinct. Here we demonstrate, for the first
time, that the hAT1R-B mRNA splice variant encodes a novel long hAT1R isoform in vivo that has
significantly diminished affinity for Ang II (i.e. >3fold) when compared with the short hAT1R isoform
(encoded by hAT1R-A mRNA splice variant). This
reduced agonist affinity caused a significant shift
to the right in the dose-response curve for Ang
II-induced inositol trisphosphate production and
Ca2ⴙ mobilization of the long hAT1R when compared with that of the short hAT1R. The functional
differences between these isoforms allows Ang II
responsiveness to be fine-tuned by regulating the
relative abundance of the long and short hAT1R
isoform expressed in a given human tissue. (Molecular Endocrinology 15: 281–293, 2001)
INTRODUCTION
The peptide hormone, angiotensin II (Ang II), the biologically active component of the renin-angiotensin
system, regulates a variety of physiological responses
including fluid homeostasis, aldosterone production,
renal function, and contraction of vascular smooth
muscle (1). Additionally, Ang II has been demonstrated
to be a growth-promoting factor in cultured rat vascu0888-8809/01/$3.00/0
Molecular Endocrinology 15(2): 281–293
Copyright © 2001 by The Endocrine Society
Printed in U.S.A.
281
MOL ENDO · 2001
282
comprised of at least four exons and spans greater than
60 kilobases (kb). Exons 1, 2, and 3 have been presumed
to constitute the 5⬘-untranslated region (UTR) mRNA
sequence, while exon 4 harbors the entire uninterrupted
open reading frame, for the hAT1R. A comparison of
several published hAT1R cDNA sequences revealed that
although these cDNA clones shared identical open reading frames, they differed in portions of their presumed
5⬘-UTR (30–32). These results suggested that alternative
splicing events combine various 5⬘-UTR exons (i.e. exons 1–3) with the same coding region exon (i.e. exon 4).
In support of this hypothesis, our laboratory demonstrated by 5⬘-rapid amplification of cDNA ends (RACE)
experiments that four distinct hAT1R mRNA splice variants are synthesized in human lung tissues (i.e. hAT1R
mRNA transcripts are comprised of exons 1 and 4; exons 1, 3, and 4; exons 1, 2, and 4; or exons 1, 2, 3, and
4) (26, 27). Sequence analysis has shown that an AUG
triplet located in exon 3 is in frame with the downstream
open reading frame located in exon 4 (29). Therefore,
hAT1R mRNA transcripts containing exons 3 and 4 may
encode a novel hAT1R with an amino-terminal extension
of 32 amino acids (long hAT1R) when compared with the
short receptor encoded by exon 1, 4 hAT1R mRNA.
Curnow et al. (29) have previously demonstrated
that the exon 1,3,4 hAT1R mRNA transcript was expressed in a number of human tissues. Additionally,
they demonstrated that human kidney 293 cells transfected with an exon 1,3,4/hAT1R expression construct
produced a functional hAT1R (29). Although these investigators demonstrated that transfected 293 cells
express hAT1Rs, they were unable to determine
whether these cells were actually expressing the long
hAT1R isoform. This is a critical consideration since
the AUG codon harbored in exon 3 is not a consensus
Kozak translation initiation start site (33). Therefore, it
is possible that the hAT1R mRNA exon 1,3,4 splice
variant does not encode the long hAT1R, but rather
encodes the short hAT1R, since translation may only
be initiated at the previously characterized AUG start
codon harbored in exon 4 (26–29). Therefore, the following study was initiated to determine whether the
long hAT1R is actually expressed in vivo and, if so, to
determine whether the long and short hAT1R isoforms
are pharmacologically and functionally distinct.
RESULTS
Tissue Distribution of hAT1R mRNA
Splice Variants
Four known distinct alternatively spliced hAT1R
mRNAs are synthesized from a single hAT1R gene.
These transcripts are comprised of exons 1 and 4
(hAT1R-A); exons 1, 3, and 4 (hAT1R-B); exons 1, 2,
and 4 (hAT1R-C); and exons 1, 2, 3, and 4 (hAT1R-D)
(Fig. 1) (26, 27). These alternatively spliced mRNAs
differ only in the lengths of their 5⬘-UTR encoded by
exons 1, 2, and 3 while exon 4 harbors the open
Vol. 15 No. 2
Fig. 1. A (...truncated)